Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
modulation of highly homologous drug-metabolizing enzymes. We are taking a hypothesis-driven and technology-enabled multidisciplinary approach to develop chemical probes and investigate biological mechanisms
-
of research. -Carry out and/or supervise laboratory experiments. -Develop experimental procedures. -Collect and analyze data. Qualifications Required Qualifications: - Ph.D. or an equivalent degree. Preferred
-
, and nutrient cycling under conservation tillage. - Strong organizational, leadership and problem-solving skills - Excellent oral and written communication skills - Experienced in developing and
-
extraction and RT-PCR. Prepare samples for next generation sequencing (NGS) and analysis of NGS data. Assist in projects involving bacteria and bacteriophages. Work after hours and on weekends as needed. Use
-
approach to develop chemical probes, investigate biological mechanisms, and evaluate in vivo efficacy. In particular we use the promiscuous pregnane X receptor (PXR) and constitutive androstane receptor (CAR
-
of Minnesota’s Masonic Institute for the Developing Brain (MIDB) under the direction of Dr. Julia Moser. This position will focus on infant neuroimaging projects. CDNI is housed at the Masonic Institute
-
by child welfare. The postdoc would receive training in community based participatory research processes as well as parent intervention development and evaluation. This is a part time position at 15
-
of Biochemistry, Molecular Biology, and Biophysics (BMBB) and the Department of Genetics, Cell Biology and Development (GCD). Salary will be according to NIH scale. For more information, please visit our lab
-
: participate in the design, implementation and evaluation of research. Carry out and supervise laboratory experiments. Develop experimental procedures. Collect and analyze data, prepare and present data
-
. However, limited availability of peritoneal dialysate has limited the impact of past attempts to introduce PD as a treatment modality. The technology being developed in our lab is a biopharmaceutical device